TIRmed Pharma develops drug candidates addressing major clinical needs.
TIRmed Pharma has raised $4.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
TIRmed Pharma's investors include Almi Invest, Sciety, Sciety Venture Partners.
TIRmed Pharma is headquartered in Stockholm, Sweden.
TIRmed Pharma develops drug candidates addressing major clinical needs.
TIRmed Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TIRmed Pharma — Funding & Investors." VCBacked, April 9, 2025, https://www.vcbacked.co/company/tirmed-pharma. Accessed July 20, 2026.
VCBacked. (2025). TIRmed Pharma — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/tirmed-pharma
{{cite web |title=TIRmed Pharma — Funding & Investors |url=https://www.vcbacked.co/company/tirmed-pharma |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated